Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;30(6):e13387.
doi: 10.1111/jsr.13387. Epub 2021 Jun 25.

European guideline and expert statements on the management of narcolepsy in adults and children

Affiliations
Free article

European guideline and expert statements on the management of narcolepsy in adults and children

Claudio L A Bassetti et al. J Sleep Res. 2021 Dec.
Free article

Abstract

Background and purpose: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and children.

Methods: The European Academy of Neurology (EAN), European Sleep Research Society (ESRS), and European Narcolepsy Network (EU-NN) nominated a task force of 18 narcolepsy specialists. According to the EAN recommendations, 10 relevant clinical questions were formulated in PICO format. Following a systematic review of the literature (performed in Fall 2018 and updated in July 2020) recommendations were developed according to the GRADE approach.

Results: A total of 10,247 references were evaluated, 308 studies were assessed and 155 finally included. The main recommendations can be summarized as follows: (i) excessive daytime sleepiness (EDS) in adults-scheduled naps, modafinil, pitolisant, sodium oxybate (SXB), solriamfetol (all strong); methylphenidate, amphetamine derivatives (both weak); (ii) cataplexy in adults-SXB, venlafaxine, clomipramine (all strong) and pitolisant (weak); (iii) EDS in children-scheduled naps, SXB (both strong), modafinil, methylphenidate, pitolisant, amphetamine derivatives (all weak); (iv) cataplexy in children-SXB (strong), antidepressants (weak). Treatment choices should be tailored to each patient's symptoms, comorbidities, tolerance and risk of potential drug interactions.

Conclusion: The management of narcolepsy involves non-pharmacological and pharmacological approaches with an increasing number of symptomatic treatment options for adults and children that have been studied in some detail.

Keywords: European; cataplexy; guideline; management; narcolepsy.

PubMed Disclaimer

References

REFERENCES

    1. Aldrich, M. S., & Rogers, A. E. (1989). Exacerbation of human cataplexy by prazosin. Sleep, 12, 254-256.
    1. Aran, A., Lin, L., Nevsimalova, S., Plazzi, G., Hong, S. C., Weiner, K., Zeitzer, J., & Mignot, E. (2009). Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep, 32, 979-983.
    1. Barateau, L., Lopez, R., Chenini, S., Pesenti, C., Rassu, A. L., Jaussent, I., & Dauvilliers, Y. (2020). Depression and suicidal thoughts in untreated and treated narcolepsy. Neurology, 95(20), e2755-e2768. https://doi.org/10.1212/WNL.0000000000010737
    1. Bassetti, C. L. A., Adamantidis, A., Burdakov, D., Han, F., Gay, S., Kallweit, U., Khatami, R., Koning, F., Kornum, B. R., Lammers, G. J., Liblau, R. S., Luppi, P. H., Mayer, G., Pollmächer, T., Sakurai, T., Sallusto, F., Scammell, T. E., Tafti, M., & Dauvilliers, Y. (2019). Narcolepsy- Clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nature Reviews Neurology, 15, 519-539.
    1. Billiard, M., Bassetti, C., Dauvilliers, Y., Dolenc-Groselj, L., Lammers, G. J., Mayer, G., Pollmächer, T., Reading, P., & Sonka, K. (2006). EFNS guidelines on management of narcolepsy. European Journal of Neurology, 13(10), 1035-1048.

Publication types